癌症生物學與藥物研發研究所

2024

Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)

Chen, M. C., Chen, C. H., Wang, J. C., Tsai, A. C., Liou, J. P., Pan, S. L. & Teng, C. M., 7月 2024, 於: Cell Death and Disease. 15, 7, 490.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

2023

Author Correction: An ATP-sensitive phosphoketolase regulates carbon fixation in cyanobacteria (Nature Metabolism, (2023), 5, 7, (1111-1126), 10.1038/s42255-023-00831-w)

Lu, K. J., Chang, C. W., Wang, C. H., Chen, F. Y. H., Huang, I. Y., Huang, P. H., Yang, C. H., Wu, H. Y., Wu, W. J., Hsu, K. C., Ho, M. C., Tsai, M. D. & Liao, J. C., 2023, (接受/付印) 於: Nature Metabolism.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

Fernandez-Rozadilla, C., Timofeeva, M., Chen, Z., Law, P., Thomas, M., Schmit, S., Díez-Obrero, V., Hsu, L., Fernandez-Tajes, J., Palles, C., Sherwood, K., Briggs, S., Svinti, V., Donnelly, K., Farrington, S., Blackmur, J., Vaughan-Shaw, P., Shu, X. O., Long, J. & Cai, Q. 及其他190, Guo, X., Lu, Y., Broderick, P., Studd, J., Huyghe, J., Harrison, T., Conti, D., Dampier, C., Devall, M., Schumacher, F., Melas, M., Rennert, G., Obón-Santacana, M., Martín-Sánchez, V., Moratalla-Navarro, F., Oh, J. H., Kim, J., Jee, S. H., Jung, K. J., Kweon, S. S., Shin, M. H., Shin, A., Ahn, Y. O., Kim, D. H., Oze, I., Wen, W., Matsuo, K., Matsuda, K., Tanikawa, C., Ren, Z., Gao, Y. T., Jia, W. H., Hopper, J., Jenkins, M., Win, A. K., Pai, R., Figueiredo, J., Haile, R., Gallinger, S., Woods, M., Newcomb, P., Duggan, D., Cheadle, J., Kaplan, R., Maughan, T., Kerr, R., Kerr, D., Kirac, I., Böhm, J., Mecklin, L. P., Jousilahti, P., Knekt, P., Aaltonen, L., Rissanen, H., Pukkala, E., Eriksson, J., Cajuso, T., Hänninen, U., Kondelin, J., Palin, K., Tanskanen, T., Renkonen-Sinisalo, L., Zanke, B., Männistö, S., Albanes, D., Weinstein, S., Ruiz-Narvaez, E., Palmer, J., Buchanan, D., Platz, E., Visvanathan, K., Ulrich, C., Siegel, E., Brezina, S., Gsur, A., Campbell, P., Chang-Claude, J., Hoffmeister, M., Brenner, H., Slattery, M., Potter, J., Tsilidis, K., Schulze, M., Gunter, M., Murphy, N., Castells, A., Castellví-Bel, S., Moreira, L., Arndt, V., Shcherbina, A., Stern, M., Pardamean, B., Bishop, T., Giles, G., Southey, M., Idos, G., McDonnell, K., Abu-Ful, Z., Greenson, J., Shulman, K., Lejbkowicz, F., Offit, K., Su, Y. R., Steinfelder, R., Keku, T., van Guelpen, B., Hudson, T., Hampel, H., Pearlman, R., Berndt, S., Hayes, R., Martinez, M. E., Thomas, S., Corley, D., Pharoah, P., Larsson, S., Yen, Y., Lenz, H. J., White, E., Li, L., Doheny, K., Pugh, E., Shelford, T., Chan, A., Cruz-Correa, M., Lindblom, A., Hunter, D., Joshi, A., Schafmayer, C., Scacheri, P., Kundaje, A., Nickerson, D., Schoen, R., Hampe, J., Stadler, Z., Vodicka, P., Vodickova, L., Vymetalkova, V., Papadopoulos, N., Edlund, C., Gauderman, W., Thomas, D., Shibata, D., Toland, A., Markowitz, S., Kim, A., Chanock, S., van Duijnhoven, F., Feskens, E., Sakoda, L., Gago-Dominguez, M., Wolk, A., Naccarati, A., Pardini, B., FitzGerald, L., Lee, S. C., Ogino, S., Bien, S., Kooperberg, C., Li, C., Lin, Y., Prentice, R., Qu, C., Bézieau, S., Tangen, C., Mardis, E., Yamaji, T., Sawada, N., Iwasaki, M., Haiman, C., Le Marchand, L., Wu, A., Qu, C., McNeil, C., Coetzee, G., Hayward, C., Deary, I., Harris, S., Theodoratou, E., Reid, S., Walker, M., Ooi, L. Y., Moreno, V., Casey, G., Gruber, S., Tomlinson, I., Zheng, W., Dunlop, M., Houlston, R. & Peters, U., 3月 2023, 於: Nature Genetics. 55, 3, p. 519-520 2 p.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Correction to: Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis (Cancers, (2021), 13, 13, (3227), 10.3390/cancers13133227)

Chen, M. Y., Yadav, V. K., Chu, Y. C., Ong, J. R., Huang, T. Y., Lee, K. F., Lee, K. H., Yeh, C. T. & Lee, W. H., 2月 2023, 於: Cancers. 15, 4, 1028.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Corrigendum to “Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer” [Biochem. Biophys. Res. Commun. 680 (2023) 161–170, (S0006291X23010616), (10.1016/j.bbrc.2023.09.025)]

Chiang, C. W., Lin, Y. S., Chang, F. L., Lin, T. Y., Tsai, K. C., HuangFu, W. C. & Lee, Y. C., 12月 17 2023, 於: Biochemical and Biophysical Research Communications. 686, 149085.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Erratum: N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling (J. Med. Chem. (2015) 58:16 (6549−6558) DOI: 10.1021/acs.jmedchem.5b00659)

Lai, M. J., Lee, H. Y., Chuang, H. Y., Chang, L. H., Tsai, A. C., Chen, M. C., Huang, H. L., Wu, Y. W., Teng, C. M., Pan, S. L., Liu, Y. M., Mehndiratta, S. & Liou, J. P., 5月 11 2023, 於: Journal of Medicinal Chemistry. 66, 9, p. 6436 1 p.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2022

Correction: Chondroitin sulfate proteoglycan 4 regulates zebrafish body axis organization via Wnt/planar cell polarity pathway (PLoS ONE (2020) 15:4 (e0230943) DOI: 10.1371/journal.pone.0230943)

Lee, Y. H., Kawakami, K., HuangFu, W. C. & Liu, I. H., 6月 2022, 於: PLoS ONE. 17, 6 June, e0270539.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Correction to: Long noncoding RNA BCRP3 stimulates VPS34 and autophagy activities to promote protein homeostasis and cell survival (Journal of Biomedical Science, (2022), 29, 1, (30), 10.1186/s12929-022-00815-0)

Yan, R. L., Luan, C. L., Liao, C. C., Liu, L. H., Chen, F. Y., Chen, H. Y. & Chen, R. H., 12月 2022, 於: Journal of Biomedical Science. 29, 1, 59.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

2021

Erratum: Melissa officinalis extract induces apoptosis and inhibits migration in human colorectal cancer cells (ACS Omega (2020) 5:49 (31792-31800) DOI: 10.1021/acsomega.0c04489)

Kuo, T. T., Chang, H. Y., Chen, T. Y., Liu, B. C., Chen, H. Y., Hsiung, Y. C., Hsia, S. M., Chang, C. J. & Huang, T. C., 2021, (接受/付印) 於: ACS Omega. 6, 8, p. 6030 1 p.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

2020

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M. & Pan, S. L., 1月 15 2020, 於: Toxicology and Applied Pharmacology. 387, 114858.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C. & Liou, J. P., 9月 1 2020, 於: European Journal of Medicinal Chemistry. 201, 112404.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

1 引文斯高帕斯（Scopus）

Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))

Mehndiratta, S., Lin, M. H., Wu, Y. W., Chen, C. H., Wu, T. Y., Chuang, K. H., Chao, M. W., Chen, Y. Y., Pan, S. L., Chen, M. C. & Liou, J. P., 8月 1 2020, 於: European Journal of Medicinal Chemistry. 199, 112406.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2019

Erratum: RAB14 activates MAPK signaling to promote bladder tumorigenesis (Carcinogenesis (bgz039) DOI: 10.1093/carcin/bgz039)

Chao, H., Deng, L., Xu, F., Fu, B., Zhu, Z., Dong, Z., Liu, Y. N. & Zeng, T., 9月 1 2019, 於: Carcinogenesis. 40, 9, p. 1177 1 p.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2018

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., 8月 17 2018, 於: Oncotarget. 9, 64, p. 32403 1 p.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

3 引文斯高帕斯（Scopus）

Correction: Two Ck1δ transcripts regulated by m6A meth-ylation code for two antagonistic kinases in the control of the circadian clock (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (5980-5985) DOI: 10.1073/pnas.1721371115)

Fustin, J. M., Kojima, R., Itoh, K., Chang, H. Y., Ye, S., Zhuang, B., Oji, A., Gibo, S., Narasimamurthy, R., Virshup, D., Kurosawa, G., Doi, M., Manabe, I., Ishihama, Y., Ikawa, M. & Okamura, H., 7月 3 2018, 於: Proceedings of the National Academy of Sciences of the United States of America. 115, 27, p. E6386

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine

Luh, F. & Yen, Y., 12月 1 2018, 於: npj Genomic Medicine. 3, 1, 28.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取

22 引文斯高帕斯（Scopus）

癌症生物學與藥物研發研究所

研究成果

搜尋結果